- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07151352
- Original Trial
Footwear and Brain Activity in Children (FooTBAC)
Footwear and Brain Activity in Children: Insights From EEG During Walking
Childhood is a critical period for neuromotor development, during which footwear may influence both gait biomechanics and the integration of sensory and motor control processes. This study will aim to analyze brain activity in children aged 6-7 years while walking under three conditions: barefoot, in barefoot-style (minimalist) shoes, and in conventional shoes with heel drop.
A quasi-experimental, repeated-measures study will be conducted, in which each participant will complete a 10-meter walking task under the three conditions, in randomized order. Brain activity will be recorded using a 14-channel wireless electroencephalography (EEG) system (Emotiv EPOC X), and relative spectral power (theta, alpha, beta, gamma) as well as Theta/Alpha and Beta/Alpha ratios will be calculated.
Statistical analysis will include global and regional comparisons (frontal, temporal, parieto-occipital), assessment of hemispheric asymmetry, and multivariate analysis. The study is expected to provide novel information on how footwear type may modulate cortical organization during children's gait, with potential implications for pediatric footwear design and clinical recommendations.
Study Overview
Status
Detailed Description
Background and Rationale Between the ages of 5 and 8 years, basic movement patterns are consolidated and brain plasticity reaches one of its highest levels. Footwear, as an external factor, may modify both gait mechanics and the quality of sensory input reaching the central nervous system. Previous studies suggest that barefoot walking or minimalist footwear may enhance intrinsic foot muscle activation and proprioception; however, limited evidence exists on how these conditions affect cortical activity in children. Electroencephalography (EEG) offers a non-invasive and real-time method to record brain activity during motor tasks, making it a suitable tool for investigating this phenomenon.
Primary Objective The primary objective will be to analyze cortical activity using EEG in children aged 6-7 years while walking under three conditions: barefoot, in barefoot-style footwear, and in conventional footwear with heel drop.
Study Design A quasi-experimental, repeated-measures, within-subject design will be used. Each participant will be assessed under all three experimental conditions, with the order randomized to minimize learning or fatigue effects.
Participants The study will include 37 healthy children aged 6 to 7 years, with no neurological or musculoskeletal disorders, normal motor development, and no habitual use of barefoot-style footwear in the past six months.
Procedure
Each participant will walk 10 meters in three conditions:
Barefoot
Barefoot-style footwear (3 mm sole, flexible, 0 mm drop, wide toe box)
Conventional footwear with heel drop (rigid sole, 12 mm heel / 7 mm forefoot, 5 mm drop, reinforced heel counter, narrow toe box).
Brain activity will be recorded using the Emotiv EPOC X wireless EEG system (14 channels) and analyzed using EEGLAB (MATLAB). Relative power in theta (4-7 Hz), alpha (8-12 Hz), beta (13-30 Hz), and gamma (30-45 Hz) frequency bands will be calculated, along with Theta/Alpha and Beta/Alpha ratios.
Statistical Analysis A repeated-measures ANOVA and Tukey's post-hoc tests will be applied to compare conditions. Regional analysis, hemispheric asymmetry evaluation, and multivariate analyses (PCA, LDA) will also be performed. Statistical significance will be set at p < 0.05.
Expected Impact This study is expected to improve understanding of how footwear type influences cortical organization during children's gait. Findings may help inform pediatric footwear design and clinical recommendations to support healthy neuromotor development.
Ethics and Consent The protocol has been approved by the Ethics Committee of the University of Málaga (CEUMA112104). Written informed consent will be obtained from parents or legal guardians, and verbal assent will be obtained from all child participants.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Malaga
-
Málaga, Malaga, Spain, 29071
- University of Malaga
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children aged 6-7 years.
- Typical motor and neurological development according to school or medical reports.
- Ability to understand and follow simple instructions.
- No regular use of barefoot-style footwear in the past six months.
- Written informed consent provided by a parent or legal guardian.
- Verbal assent provided by the child in an age-appropriate manner.
Exclusion Criteria:
- Diagnosed neurodevelopmental disorders (e.g., ADHD, autism spectrum disorder, motor dysfunction).
- Orthopedic or neuromuscular conditions affecting gait (e.g., equinus foot, cerebral palsy).
- Lower-limb surgery within the previous 6 months.
- Use of medication affecting alertness, muscle tone, or motor control.
- Scalp lesions or intolerance to EEG headset use.
- Any condition that, in the investigator's judgment, could interfere with study participation or data integrity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Starting Condition - Barefoot
Participants will first complete the walking task barefoot along a 10-meter walkway.
They will then perform the same task in barefoot-style (minimalist) footwear and in conventional footwear with heel drop.
The order of the second and third conditions will be randomized.
EEG will be recorded during all walking trials, with rest periods between conditions.
|
Participants walk barefoot along a 10-meter walkway without wearing shoes or socks.
Other Names:
Participants walk along a 10-meter walkway wearing minimalist footwear with a 3 mm flexible sole, 0 mm heel drop, wide toe box, and no rigid heel counter.
Other Names:
Participants walk along a 10-meter walkway wearing structured footwear with a rigid sole (12 mm heel / 7 mm forefoot), 5 mm heel drop, reinforced heel counter, and narrow toe box.
Other Names:
|
|
Experimental: Starting Condition - Barefoot-Style Footwear
Participants will first complete the walking task in barefoot-style (minimalist) footwear with a 3 mm flexible sole, 0 mm heel drop, wide toe box, and no rigid heel counter.
They will then perform the task barefoot and in conventional footwear with heel drop.
The order of the second and third conditions will be randomized.
EEG will be recorded during all walking trials, with rest periods between conditions.
|
Participants walk barefoot along a 10-meter walkway without wearing shoes or socks.
Other Names:
Participants walk along a 10-meter walkway wearing minimalist footwear with a 3 mm flexible sole, 0 mm heel drop, wide toe box, and no rigid heel counter.
Other Names:
Participants walk along a 10-meter walkway wearing structured footwear with a rigid sole (12 mm heel / 7 mm forefoot), 5 mm heel drop, reinforced heel counter, and narrow toe box.
Other Names:
|
|
Active Comparator: Starting Condition - Conventional Drop Footwear
Participants will first complete the walking task in conventional structured footwear with a rigid sole (12 mm heel / 7 mm forefoot), 5 mm heel drop, reinforced heel counter, and narrow toe box.
They will then perform the task barefoot and in barefoot-style footwear.
The order of the second and third conditions will be randomized.
EEG will be recorded during all walking trials, with rest periods between conditions.
|
Participants walk barefoot along a 10-meter walkway without wearing shoes or socks.
Other Names:
Participants walk along a 10-meter walkway wearing minimalist footwear with a 3 mm flexible sole, 0 mm heel drop, wide toe box, and no rigid heel counter.
Other Names:
Participants walk along a 10-meter walkway wearing structured footwear with a rigid sole (12 mm heel / 7 mm forefoot), 5 mm heel drop, reinforced heel counter, and narrow toe box.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative spectral power ratios (Theta/Alpha, Beta/Alpha) during walking in children
Time Frame: Day 1 (single data collection session)
|
EEG-based measurement of relative spectral power in theta (4-7 Hz), alpha (8-12 Hz), and beta (13-30 Hz) frequency bands, and calculation of Theta/Alpha and Beta/Alpha ratios across three footwear conditions (barefoot, barefoot-style, conventional with heel drop).
EEG will be recorded using a 14-channel Emotiv EPOC X system during a 10-meter walking task.
Analyses will compare regional and global cortical activity patterns between conditions.
|
Day 1 (single data collection session)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UCCSSMalaga
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children
-
Elizabeth Glaser Pediatric AIDS FoundationUnited States Agency for International Development (USAID); Biomedical Research... and other collaboratorsTerminatedOrphans, Children, Adolescents | Vulnerable Children, Adolescents | Community-basedZimbabwe
-
Duke UniversityBoston Children's Hospital; Agency for Healthcare Research and Quality (AHRQ)CompletedChildren, Only | Children and Youth With Special Healthcare NeedsUnited States
-
National Institute of Mental Health (NIMH)RecruitingHealthy Children | Children With Neurodevelopmental Disorders | Children With Neuropsychiatric Disorders | Children With Behavioral SyndromesUnited States
-
Centre Hospitalier St AnneCentre National de la Recherche Scientifique, France; Université Paris CitéNot yet recruitingChildren | Typical Development | FRENCH STUDY | Children Behavior Problem | Typical Preschoolers Who Can Not Zipper | Typically Developing Children Ages 3 to 6
-
University of PaviaNot yet recruiting
-
Georgetown UniversityPenn State UniversityCompleted
-
Sheffield Children's NHS Foundation TrustUniversity of Sheffield; Sheffield Hallam UniversityCompletedChildrenUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedChildrenUnited States
Clinical Trials on Starting Condition - Barefoot
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Elisabetta BrigoRecruitingPlantar Fasciitis | Plantar Fasciopathy | Plantar Fasciitis, Chronic | Heel PainIreland
-
University of Sao PauloCompleted
-
VA Puget Sound Health Care SystemCompletedDiabetes (DM) | Lower Limb Amputation Below Knee | Vascular Reactivity | Skin Temperature ChangeUnited States
-
Universidade Estadual de LondrinaCompleted
-
University Hospital, LilleCompletedHemodynamic Monitoring | Fluid ChallengeFrance
-
University of LiverpoolLiverpool University Hospitals NHS Foundation TrustCompletedAging | FallsUnited Kingdom
-
University Hospital, Basel, SwitzerlandRecruiting
-
University of FloridaCompleted